News|Articles|November 5, 2025

Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care

Experts discuss the implications of the Most Favored Nation drug policy, discussing its impact on pricing, community pharmacy, and patient safety in the final part of a webinar series.

On November 4, 2025, policy and economics experts convened for the third installment of a webinar series discussing the Most Favored Nation (MFN) Drug Policy Executive Order. Presented by MJH Life Sciences in partnership with a variety of its brands, including Drug Topics, the final part of the webinar series focuses on helping all stakeholders involved understand the potential implications of the groundbreaking MFN drug policy.